Studies identify food sources of disease and drug resistanceOctober 04, 2006As the recent U.S. outbreak of E. coli infections caused by contaminated spinach demonstrates, the safety of the food we eat cannot be taken for granted. Two studies in the Nov. 1 issue of The Journal of Infectious Diseases, now available online, further illustrate the point, one adding a new bacterial culprit to the mix and the other showing that use of antibiotics as growth promoters in livestock increases the risk of antibiotic resistance in humans. In one study, investigators led by Katri Jalava, DVM, of the Finnish National Public Health Institute, and J. Pekka Nuorti, MD, DSc, of the National Centers for Disease Control and Prevention, traced an outbreak of Yersinia pseudotuberculosis infection among children in a Finnish town to carrots grown on a single farm. An epidemiologic investigation linked illness to eating raw carrots. Laboratory tests confirmed that the bacteria in infected children's stool samples were indistinguishable from the bacteria isolated from the farm. The authors noted that this marked the first time that the bacterium had been recovered from an epidemiologically implicated source of food-borne illness. They pointed out that it is well known as a pathogen in wild mammals, and that the farm stored the carrots in a barn in open containers for months. "A combination of direct contact with wildlife feces during storage and cross-contamination during washing and peeling," they concluded, "are the most likely contributing factors." To prevent such outbreaks, "regulations addressing the production, storage and shipping conditions for fresh produce are needed." In the other study, Edward A. Belongia, MD, and colleagues at the Marshfield Clinic Research Foundation, Marshfield, Wis., and elsewhere examined poultry exposure as a risk factor for antibiotic resistance by Enterococcus faecium, a gut bacterium that is an increasing cause of hospital infections. A drug combination called quinupristin-dalfopristin, also known as Synercid, is used to treat serious E. faecium infections that are resistant to the first-choice antibiotic. Synercid is related to virginiamycin, an antibiotic that has long been used as a growth promoter in U.S. livestock but is now banned in Europe. The question Dr. Belongia and colleagues asked was, does exposing poultry to virginiamycin lead to Synercid-resistant E. faecium in humans? The group isolated E. faecium in stool samples from 105 newly hospitalized patients and 65 healthy vegetarians, and in 77 samples of conventional retail poultry and 23 antibiotic-free poultry meat samples. Laboratory tests showed that the bacteria isolated from patients and vegetarians had no pre-existing resistance to Synercid. Resistance was rare among antibiotic-free poultry, but a majority of bacterial isolates from conventional poultry samples were resistant. After exposure to virginiamycin, E. faecium from conventional poultry and from patients who consumed poultry became resistant to Synercid more often than E. faecium from vegetarians or from antibiotic-free poultry. Some of the resistance was attributed to a specific gene, and both the gene and resistance were associated with touching raw poultry meat and frequent poultry consumption. In an editorial commenting on the studies, Niels Frimodt-Møller, MD, DMSc, and Annette M. Hammerum, PhD, MSc, of the Danish National Center for Antimicrobials and Infection Control, observed that the findings are "examples of how industrialization of food production carries and even amplifies risk for unaware consumers." To reduce or remove the risk of food contamination as documented by the Finnish team, they noted, requires multiple measures at multiple levels, such as growing and storing carrots away from animals and encouraging hygienic practices for harvesters and harvesting machinery. To reduce or remove the risk of resistant gut bacteria, however, the editorial authors say the answer is easy: "Ban antibiotic growth promoters!" Infectious Diseases Society of America |
|||||||||||||||||||||
| Related Drug Resistance Current Events and Drug Resistance News Articles Taking aim at mysterious DNA structures in the battle against cancer Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. There's a speed limit to the pace of evolution, Penn biologists say Researchers at the University of Pennsylvania have developed a theoretical model that informs the understanding of evolution and determines how quickly an organism will evolve using a catalogue of "evolutionary speed limits." Ineffective monotherapies common in high-burden malarious countries ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk. Paradigm shift needed to combat drug resistance When people travel, bacteria and other infectious agents travel with them. As about a billion people cross international borders each year, many more billions of the bugs come along for the ride. UM School of Medicine researchers find extreme genetic variability in malaria parasite Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. Scientists join forces to explain HIV spread in Central and East Africa Scientists studying biology and geography may seem worlds apart, but together they have answered a question that has defied explanation about the spread of the HIV-1 epidemic in Africa. Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease. MUHC/McGill researchers to WHO: Time to revise tuberculosis treatment guidelines Tuberculosis is a global threat that affects more than 10 million people each year. Working with colleagues in the United States and France, Dr. Dick Menzies of the Research Institute of the McGill University Health Centre (RI-MUHC) has placed current tuberculosis treatment guidelines under the microscope in a new study. Man-made crises 'outrunning our ability to deal with them,' scientists warn The world faces a compounding series of crises driven by human activity, which existing governments and institutions are increasingly powerless to cope with, a group of eminent environmental scientists and economists has warned. New research strategy for understanding drug resistance in leukemia UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies. More Drug Resistance Current Events and Drug Resistance News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||